Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Danaher Digital Transformation Strategy Analysis Report 2026: Technology Focus and Initiatives, Partnerships and Acquisitions, ICT Budget & Contracts, Tech Ecosystem

globenewswire.com
DHR The article discusses Danaher's digital transformation strategy, technology initiatives, partnerships, acquisitions, and ICT budgets/contracts. It provides an overview of the company's operations in life sciences, diagnostics, and biotechnology, mentioning several key operating companies. The sentiment is neutral as it's a factual report.

Danaher Digital Transformation Strategy Analysis Report 2026: Technology Focus and Initiatives, Partnerships and Acquisitions, ICT Budget & Contracts, Tech Ecosystem Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Danaher Corp. - 2026" company profile has been added to ResearchAndMarkets.com's offering.

The report provides detailed information and insights into Danaher's technology activities, including its digital transformation strategies and innovation programs. It offers an overview of key technology initiatives, covering partnerships, product launches, and acquisitions, along with insights into each initiative’s technology theme, objectives, and benefits. Additionally, the report includes details on estimated ICT budgets and major ICT contracts.

Danaher Corp (Danaher) is a life sciences and diagnostics company focused on leveraging science and technology to improve human health. It comprises more than 15 operating companies in the life sciences, diagnostics and biotechnology sectors. These companies are organized under three segments: Life Sciences, Diagnostics and Biotechnology.

The Life Sciences segment offers instruments, consumables, services and software for studying DNA, RNA, cells, metabolites, proteins, and nucleic acids. The Diagnostics segment offers clinical instruments, software, consumables, and services for the diagnosis of various diseases. The Biotechnology segment offers equipment, consumables and services for the discovery, development and production of biological medicines.

Some of the key operating companies of Danaher are Integrated DNA Technologies (IDT), Cytiva, Beckman Coulter Life Sciences, Molecular Devices, Leica, Mammotome, and Cepheid.

Reasons to Buy

Key Topics Covered:

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this company profile visit https://www.researchandmarkets.com/r/fs1iaj

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.